US6907321029
US6907321029
Accendra Health, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 32.92M EUR | 263.01M EUR | 174.61M EUR | 213.89M EUR |
Enterprise Value | 1.85B EUR | 2.04B EUR | 2.01B EUR | 2.05B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 4.69x | -- | -- | -- |
Price to Sales | 0.01x | 0.1x | 0.06x | 0.1x |
Price to Book | -- | -- | -- | -- |
EV/Revenue | 0.7x | 0.77x | 0.74x | 0.98x |
EV/EBITDA | 6.41x | 5.05x | 4.82x | 6.15x |
Price to FCF (P/FCF) | 0.08x | -- | -- | -- |
EV/FCF | 4.39x | -- | -- | -- |
FCF Yield | 1,276.71% | -139% | -178.97% | -102.82% |